Please login to the form below

Not currently logged in

Orchard Therapeutics

This page shows the latest Orchard Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Bicycle Therapeutics looks to raise $86m with IPO

Bicycle Therapeutics looks to raise $86m with IPO

Key data readout expected later this year. UK biotech company Bicycle Therapeutics is to launch an IPO via the US Nasdaq exchange to raise $86.25m. ... In November last year, gene therapy specialist Orchard Therapeutics raised over $200m, while CAR-T

Latest news

More from news
Approximately 6 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    drugs, Novartis’ Kymriah and Gilead/Kite’s Yescarta and Spark Therapeutics’ gene therapy Luxturna all reaching the market last year. ... GSK has also had very limited success with Strimvelis and has now sold on the treatment to UK-based gene

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...